Video Choledochoscopes segmentation by application delineates three primary use‑cases that collectively drive market revenue. The Diagnostic segment, accounting for roughly 45 % of sales, supports intra‑operative visualization of the biliary tree to confirm anatomy and detect pathology, thereby influencing procurement decisions of high‑volume hepatobiliary centers. The Therapeutic segment, representing about 40 % of the market, is linked to interventions such as stone extraction, stricture dilation, and stent placement; its growth is propelled by rising incidence of choledocholithiasis and expanding minimally invasive surgery programs. The remaining 15 % falls under Research & Training, where institutions acquire scopes for simulation labs and clinical studies, contributing a modest but steady revenue stream. Collectively, these application categories shape the overall Video Choledochoscopes market size, with each segment’s share reflecting clinical demand intensity and reimbursement dynamics. Projected demographic shifts and increasing adoption of laparoscopic procedures are expected to elevate the diagnostic share to near 50 % by 2030, reinforcing its dominant role in market composition.